TABLE 1. Measurement and Subject Characteristics.
Training Data | Testing Data | ||||
---|---|---|---|---|---|
Cohort 1 | Cohort 2 | Cohort 1 | Cohort 2 | Cohort 3 | |
Measurement Characteristics | |||||
Device | Omron | Microlife | Omron | Microlife | Microlife |
Reference | Invasive | Invasive | Invasive | Invasive | Auscultation |
# of Subjects | 20 | 37 | 58 | 11 | 19 |
# of Baseline Measurements | 20 | 37 | 36 | 11 | 19 |
# of Nitroglycerin Measurements | 8 | 36 | 32 | 11 | 0 |
# of Repeated Measurements | 0 | 73 | 0 | 16 | 16 |
Total # of Measurements | 28 | 146 | 68 | 38 | 35 |
Subject Characteristics | |||||
Type | Cardiac Catheterization | Normal | |||
Age [years] | 65.1±15.4 | 65.2±12.3 | 59.8±15.0 | 69.0±12.4 | 34.0±9.4 |
Weight [kg] | 64.5±12.4 | 74.6±13.4 | 70.12±11.5 | 68.9±14.2 | 60.4±15.8 |
Height [cm] | 164.0±6.4 | 163.6±8.0 | 161.6±7.8 | 162.2±10.4 | 164.2±9.3 |
Waist circumference [cm] | 84.6±11.4 | 90.0±12.3 | 91.8±9.5 | 97.2±11.9 | 75.8±11.2 |
Men [%] | 85 | 75.7 | 74.1 | 72.7 | 36.8 |
Smoking [%] | 35 | 18.9 | 20.7 | 27.3 | N/A |
Clinical diagnosis [%] | |||||
Hypertension | 65 | 59.5 | 56.9 | 90.9 | N/A |
Type 2 Diabetes Mellitus | 20 | 29.7 | 31 | 54.5 | N/A |
Dyslipidemia | 45 | 37.8 | 41.4 | 36.4 | N/A |
Coronary Artery Disease | 40 | 59.5 | 56.9 | 63.6 | N/A |
Chronic Renal Failure | 5 | 2.7 | 3.4 | 18.2 | N/A |
Medications [%] | |||||
Blockers | 20 | 13.5 | 12.1 | 27.3 | N/A |
Blockers | 30 | 43.2 | 37.9 | 63.6 | N/A |
Calcium Channel Blockers | 25 | 48.6 | 41.4 | 27.3 | N/A |
Diuretics | 20 | 18.9 | 20.7 | 36.4 | N/A |
Antiplatelet Agents | 65 | 86.5 | 70.7 | 81.8 | N/A |